Levia® and Personal Targeted Phototherapy Introduced to Dermatology Nurses as a Psoriasis Treatment Option

Share Article

Levia, cleared by the FDA for physician-directed use, is specifically designed to provide Personal Targeted Phototherapy with ultraviolet B (UVB) light, privately and conveniently, in a patient’s home was launched today at the 28th Annual Convention Dermatology Nurses Association (DNA).

“UVB phototherapy is seriously under-utilized even though it is a minimal side-effect, non-drug treatment option, and effective for 85% of psoriasis patients,” said Ethan Lerner, M.D., Ph.D., a dermatologist and LMD’s founder.

Lerner Medical Devices, Inc., (LMD) today introduced Levia, an innovative medical device for self-treatment at home of psoriasis, to the Dermatology Nurses Association (DNA), at their 28th Annual Convention, Booth Number 517, Disney’s Contemporary Resort, Lake Buena Vista, Florida. Levia, cleared by the FDA for physician-directed use, is specifically designed to provide Personal Targeted Phototherapy with ultraviolet B (UVB) light, privately and conveniently, in a patient’s home.

“Over the years, psoriasis patients have shared with me the embarrassment, pain and suffering that comes from living and dealing with this condition,” said Pamela Morgan, R.N., DNC, coauthor and lecturer of “The Fundamentals of Phototherapy: The Joan Shelk Memorial Workshop,” at the DNA Convention. “Privacy is a key element in effective long-term therapy. Psoriasis may be a skin condition but it can burrow deep into self-esteem, leaving patients feeling despondent and powerless. For this reason, individual control in a home setting, as represented by Levia and Personal Targeted Phototherapy, is an empowering treatment option for psoriasis sufferers.”

An essential focus for Levia will be to provide intensive case management and caring customer service to home-based patients, with a clinical support team led by Linda J. Hornbeek, R.N., D.N.C., Senior Nurse Educator of LMD. “Treating themselves at home gives patients both freedom and personal control over their condition. However, it is also a very important part of our service that Levia users receive full training at the outset and continued access to ongoing support, including co-ordination with their physicians and nurses, if necessary.”

Levia represents a new class of home phototherapy device, incorporating “smart” technology and software for physician control of dosimetry. In addition, two proprietary beam-delivery attachments - LiteSpot™ and LiteBrush™ - ensure precise delivery of UVB light to the affected areas of skin and scalp respectively.

“UVB phototherapy is seriously under-utilized even though it is a minimal side-effect, non-drug treatment option, and effective for 85% of psoriasis patients,” said Ethan Lerner, M.D., Ph.D., a dermatologist and LMD’s founder. “We believe that convenient and cost-effective home treatment, in conjunction with the purpose designed Levia technology, can transform the utilization level of UVB phototherapy, to the benefit of potentially millions of psoriasis patients.”

About Lerner Medical Devices, Inc:    
Lerner Medical Devices, Inc. is focused on the use of ultraviolet light therapy for self-treatment of psoriasis and other photo-responsive skin conditions. Levia® is the first of their Personal Targeted Phototherapy products; it is designed to facilitate safe treatment of psoriasis in a home environment, incorporating:

  •     Proprietary beam delivery attachments to direct UVB light precisely to

             the affected areas of skin and scalp.

  •     Touch screen interface for maximum control by patients in accordance

             with preset instructions from the prescribing physician.

To learn more about Levia and Lerner Medical, please visit http://www.mylevia.com and http://www.lernermedical.com.

Find us on Facebook: http:/http://www.facebook.com/mylevia
Follow us on Twitter: http://www.twitter.com/mylevia

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kelly Rice
QuantumMethod
310.601.4377 ext. 103
Email >

John Lyon
Visit website